Research Article

Anti-GAPDH Autoantibody Is Associated with Increased Disease Activity and Intracranial Pressure in Systemic Lupus Erythematosus

Table 1

Characteristics of 130 SLE patients and 55 healthy controls.

SLEControl

Age0.2300.818
Gender (F : M)120 : 1049 : 60.5060.477
WBC5.300 (3.638, 7.710)
HB
PLT162.0 (115.0, 237.5)
D-dimer248.0 (106.0, 658.0)
IgG15.90 (11.55, 19.85)
IgA2.480 (1.770, 3.860)
IgM0.9710 (0.634, 1.415)
C30.5970 (0.427, 0.840)
C40.1230 (0.062, 0.184)
ESR30.00 (17.00, 56.00)
RF30 (23.62%)
CRP4.750 (1.903, 12.28)
CK28.50 (18.25, 45.75)
Cr53.00 (45.00, 66.00)
Anti-dsDNA46.65 (10.20, 182.3)
AnuA33.76 (6.948, 164.5)
Anti-SSA53.91%
Anti-SSB11.72%
Anti-RNP49.61%
71.09%
SLEDAI-64.62%

F: female; M: male; WBC: white blood cell; HB: hemoglobin; PLT: platelet count; IgG: immunoglobulin G; IgA: immunoglobulin A; IgM: immunoglobulin M; C3: complement component 3; C4: complement component 4; ESR: erythrocyte sedimentation rate; RF: rheumatoid factor; CRP: C-reaction protein; CK: creatine kinase; Cr: creatinine; anti-dsDNA: anti-double-stranded DNA antibodies; AnuA: anti-nucleosome antibodies; anti-SSA: anti-SSA antibody; anti-SSB: anti-SSB antibody; anti-RNP Abs: anti ribonucleoprotein (RNP) antibodies; ANA: anti-nuclear antibodies; SLEDAI-2K: systemic lupus erythematosus disease activity index 2000.